Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | ADH1C | P00326 | 1/20 | 0.42 |
| ▸ | ADH1A | P07327 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13462953 | 0.85 | ALDH1A1 (0.50) | KMT2AMEN1ALDH1A1TSHRSMN1; SMN2 | |
| M-Xylene SCHEMBL8433561 | 0.84 | KMT2A (0.46) | KMT2AMEN1ALDH1A1TSHRPOLB | |
| Resorcinol SCHEMBL11664139 | 0.84 | KMT2A (0.49) | KMT2AMEN1ALDH1A1TSHRPOLB | |
| SCHEMBL10993193 | 0.84 | ALDH1A1 (0.38) | KMT2AMEN1ALDH1A1TSHRADH1C | |
| SCHEMBL10912846 | 0.84 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1ATMKDM4E | |
| SCHEMBL9357964 | 0.82 | TSHR (0.49) | KMT2AMEN1ALDH1A1TSHRADH1C | |
| SCHEMBL14920073 | 0.82 | ALDH1A1 (0.42) | KMT2AMEN1ALDH1A1TSHRADH1C | |
| SCHEMBL10388017 | 0.81 | KMT2A (0.37) | KMT2AMEN1ALDH1A1TSHRADH1C | |
| SCHEMBL1837926 | 0.81 | ALDH1A1 (0.44) | KMT2AMEN1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL10988348 | 0.81 | ALDH1A1 (0.44) | KMT2AMEN1ALDH1A1TSHRADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0228272-A2 | Preparation of urethane substituted diacetylene monomers and polymers | GTE LABORATORIES INCORPORATED (US) | 1987-07-08 | — | — | EP | claimed |
| EP-4728003-A1 | HUMIDITY CURABLE TWO-COMPONENT SYSTEM COMPRISING ACCELERATOR | Zephyros Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| WO-2024256486-A1 | HUMIDITY CURABLE TWO-COMPONENT SYSTEM COMPRISING ACCELERATOR | ZEPHYROS, INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20240059891-A1 | Composition Comprising Silyl-Modified Prepolymer and Highly Structured Carbon Black | ZEPHYROS, INC. | 2024-02-22 | — | — | US | disclosed |
| EP-4259709-A1 | COMPOSITION COMPRISING SILYL-MODIFIED PREPOLYMER AND HIGHLY STRUCTURED CARBON BLACK | Zephyros Inc. (US) | 2023-10-18 | — | — | EP | disclosed |
| US-11518904-B2 | Curable coating compositions | SWIMC LLC (US) | 2022-12-06 | — | — | US | disclosed |
| WO-2022122782-A1 | COMPOSITION COMPRISING SILYL-MODIFIED PREPOLYMER AND HIGHLY STRUCTURED CARBON BLACK | ZEPHYROS, INC. (US) | 2022-06-16 | — | — | WO | disclosed |
| EP-2756353-B1 | PATTERN-FORMING METHOD, ELECTRON BEAM-SENSITIVE OR EXTREME ULTRAVIOLET RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, MANUFACTURING METHOD OF ELECTRONIC DEVICE USING THEM AND ELECTRONIC DEVICE | FUJIFILM CORP (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-9199934-B2 | Alpha-hydroxyketones | BASF SE (DE) | 2015-12-01 | — | — | US | disclosed |
| EP-2129659-B1 | ALPHA-HYDROXYKETONES | BASF SE (DE) | 2013-05-29 | — | — | EP | disclosed |
| US-20100104979-A1 | ALPHA-HYDROXYKETONES | IGM GROUP B.V. (NL) | 2010-04-29 | — | — | US | disclosed |
| EP-0228272-A2 | Preparation of urethane substituted diacetylene monomers and polymers | GTE LABORATORIES INCORPORATED (US) | 1987-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100104979-A1 | ALPHA-HYDROXYKETONES | C9, C1R, CBR3 | KMT2A 2928/4885MEN1 2626/4885ALDH1A1 734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.